Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Daiichi Sankyo
Covington
Farmers Insurance
US Department of Justice
Baxter
Johnson and Johnson
Federal Trade Commission
Mallinckrodt

Generated: April 22, 2018

DrugPatentWatch Database Preview

Hydrochlorothiazide; triamterene - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydrochlorothiazide; triamterene and what is the scope of hydrochlorothiazide; triamterene freedom to operate?

Hydrochlorothiazide; triamterene
is the generic ingredient in four branded drugs marketed by Glaxosmithkline Llc, Ani Pharms Inc, Casi Pharms Inc, Duramed Pharms Barr, Ivax Sub Teva Pharms, Lannett Holdings Inc, Mylan, Novartis, Sandoz, Vitarine, Mylan Pharms Inc, Am Therap, Apotex Inc, Pliva, Quantum Pharmics, and Watson Labs, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for hydrochlorothiazide; triamterene. Thirty-seven suppliers are listed for this compound.
Summary for hydrochlorothiazide; triamterene
Pharmacology for hydrochlorothiazide; triamterene
Synonyms for hydrochlorothiazide; triamterene
14124-50-6
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide, mixt. with 6-phenyl-2,4,7-pteridinetriamine
6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine- 7-sulfonamide, 1,1-dioxide, mixt. with 6-phenyl-2,4,7-pteridinetriamine
AC1L1Y34
C12H11N7.C7H8ClN3O4S2
DTXSID50161615
Dytide H
HE310127
Hydrochlorothiazide - triamterene mixt.
Hydrochlorothiazide and triamterene
Hydrochlorothiazide mixture with Triamterene
Hydrochlorothiazide-triamterene
LS-178541
Novotriamazide
SCHEMBL931483
Slimin
Triampur (combination)
Triampur compositum
Triamterene - hydrochlorothiazide mixt.
Triamterene / HCTZ
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Triamterene hydrochlorothiazide
Triamterene mixture with hydrochlorothiazide
Triamterene/HCTZ
Triamterene/hydrochlorothiazide

US Patents and Regulatory Information for hydrochlorothiazide; triamterene

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene TABLET;ORAL 071851-001 Nov 30, 1988 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc MAXZIDE hydrochlorothiazide; triamterene TABLET;ORAL 019129-001 Oct 22, 1984 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Casi Pharms Inc TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene CAPSULE;ORAL 073191-001 Jul 31, 1991 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pliva TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene TABLET;ORAL 074026-001 Apr 26, 1996 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for hydrochlorothiazide; triamterene

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Pharms Inc MAXZIDE-25 hydrochlorothiazide; triamterene TABLET;ORAL 019129-003 May 13, 1988 ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc MAXZIDE hydrochlorothiazide; triamterene TABLET;ORAL 019129-001 Oct 22, 1984 ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc MAXZIDE hydrochlorothiazide; triamterene TABLET;ORAL 019129-001 Oct 22, 1984 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Harvard Business School
Healthtrust
Farmers Insurance
Express Scripts
Chubb
Deloitte
Cantor Fitzgerald
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.